DRL’s semaglutide supply hits a stumbling block, affects other companies too

India's Dr Reddy's sees semaglutide supply disruption lasting until at least late October

Independent US body finds drug shortages are lasting longer as reliability dwindles

How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies

The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as

Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure

This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont

JAMA Study Points to Fragile Supply Chain, Not Over-Prescribing, as Cause of ADHD Medication Shortage

The article examines the root causes of the ADHD medication shortage, arguing that public discourse has wrongly focused on over-prescribing

Government likely to delay 25% ethanol blend in petrol amid backlash